Nicole Albanese grew up in a holistic household that emphasized diet over drugs. Now, as a clinical associate professor of pharmacy practice at the University at Buffalo, she embraces medication—but as only one piece of the overall health puzzle. In this episode, Albanese, whose research focuses on diabetes, obesity and nutrition, talks to host Laurie Kaiser about the pros and cons of modern weight-loss drugs. Their conversation covers everything from unforeseen side effects to unexpected health benefits, with discussions along the way on how these drugs work, why they’re so hugely popular, what prevents most users from achieving long-term success, and what’s next on the horizon. Hint: It won’t be long before we’re looking back on Ozempic and Wegovy as weight-loss drugs 1.0.
Credits:
Host: Laurie Kaiser
Guest: Nicole Albanese
Writer/Producer: Laura Silverman
Production and editing by UB Video Production Group
Coming March 31: A pioneer in the field of neurovascular disease, Elad Levy helped establish thrombectomy as the standard of care for stroke and was among the first to implant a brain-computer interface enabling people with limited mobility to operate devices with their thoughts. In the next episode, he discusses these and other groundbreaking achievements—and offers a preview of the innovations he’s advancing now.
